Nasal sprays are key in managing congestion, using saline for moisture, decongestants for swelling, and steroids for deeper ...
Drugmaker GSK shared positive results Monday from two Phase 3 trials testing its inflammatory disease drug depemokimab in people with a condition known as chronic rhinosinusitis with nasal polyps.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback